Grow Sample Demand 3-28X
An Innovative Vision
SymmetryRx will be recognized by pharma, practitioners, and health systems as the company that understands and delivers on their needs related to drug sampling. SymmetryRx is a precision innovator able to meet the requirements across the sampling ecosphere. We expect to be viewed as the company with the utilities that generate new prescription demand and make the industry better. Our business model enables us to uniquely partner with all stakeholders in pursuit of superior patient care.
About SymmetryRx
With over two decades of innovation for pharma, beginning with creating the original eSample® platform, SymmetryRx has generated exceptional sample demand for its pharma clients. Our name encompasses the idea of balance and guides our company philosophy. SymmetryRx balances business, operational, compliance and patient needs in the ever evolving drug sampling ecosystem. Today, our stakeholders can experience a 100% digital transaction, home shipment of samples to patients, and medication adherence services that are proven to align patient days on therapy to their HCP’s plan.
Hal Walsh
Hal Walsh, Chief Executive Officer provides SymmetryRx with vision, leadership and strategy to build innovative online solutions and services that increase the reach of pharmaceutical manufacturers to prescribers and to patients.
Hal is known for harnessing available resources, creatively filling resource gaps, and quickly operationalizing opportunities for the benefit of patients, physicians, practices and partners. He has over 35 years of award-winning performance in the development and launch of new clinical and operational technologies in the healthcare sector. Hal grew up in Ventnor, NJ and holds a Bachelor of Science in Business Administration, with a major in Finance, from Villanova University. To learn more about Hal’s professional journey and SymmetryRx, please read his 2021 feature in Beyond Exclamation Magazine here.